Dosifix® SafeSetIV administration set with dosing container.

In gravity infusion, Dosifix® SafeSet allows a precise dosage of solution which is given to the patient. This functionality is particularly important for neonatal, pediatric and geriatric care. In gravity or pump-controlled* flow-situations Dosifix® SafeSet is also used for an intermittent infusion of medication in its correct dilution in a closed system with the ability to flush the IV line after each application for mono and multiple therapy without the need to re-spike.

Read more

In gravity infusion, Dosifix® SafeSet allows a precise dosage of solution which is given to the patient. This functionality is particularly important for neonatal, pediatric and geriatric care. In gravity or pump-controlled* flow-situations Dosifix® SafeSet is also used for an intermittent infusion of medication in its correct dilution in a closed system with the ability to flush the IV line after each application for mono and multiple therapy without the need to re-spike.

References

1  Ker, G. L., Gangadharan, S. (2018): Management of Fluid Overload in the Pediatric ICU, Pediatric Critical Care, July 2018, pp. 193–209. Foland, J.A., Fortenberry, J.D., Warshaw, B. L. et al. (2004): Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis, Crit Care Med. 2004 Vol. 32, No. 8, pp. 1771–1776. 3  Del Granado, R. C. and Mehta, R. L. (2016): Fluid overload in the ICU: evaluation and management, Nephrology 17, p. 109. 4  WHO (2013): Hospital Care for Children. Guidelines for the Management of Common Childhood Illnesses, 2nd edition. Geneva. Engineering data on file. 6  Plagge, H., Golmich, J., Brnanad, D., et al. (2010): Evaluation of the dead volume in intravenous short-term infusion, Pharma Publishing and Media Europe, Volume 16, Issue 2, pp. 31-37. 7  Federal Institute of Drugs and Medicinal Devices (2015): The Forgotten Residue: Dead Volumes of Short-term Infusions, Pub. No. 2, June 2015. 8  National Institute for Occupational Safety and Health (2004): NIOSH alert 2004-165. Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings, CDC, Cincinnati, OH.